Trueman, S., Wu, L., Girgis, S., Vaidya, K., Meric-Bernstam, F., Harding, J. J., Pant, S., Zhao, Y., Garfin, P. M., Iannone, R., Zhou, H., Ma, J. (2025). Zanidatamab dose optimization in patients with HER2-positive biliary tract cancer (BTC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.546